Human breast cancer in vivo: H-1 and P-31 MR spectroscopy at 1.5 T. Radiology 1988; 169: 615–20., , , , , .
Gribbestad IS. High-resolution magic angle spinning MRS of breast cancer tissue. NMR Biomed 2002; 15: 327–37., , , ,
2009; 22: 65–76., , , , , , et al. Metabolite quantification and high-field MRS in breast cancer. NMR Biomed
American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin 2000; 50: 34–49., , , .
Clinical Oncology. 2nd edn. Oxford: Churchill Livingstone, 1999., , , , . Breast. In , , , Eds.
Recent developments in breast imaging. Phys Med Biol 1996; 41: 315–68., .
Mammography and Beyond. Washington, DC: National Academy Press, 2001., , .
The application of breast MRI in staging and screening for breast cancer. Oncology (Williston Park) 2005; 19: 159–69; discussion 170, 173–4, 177..
Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 2004; 351: 427–37., , , , , , et al.
Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer 2005; 103: 1898–905., , , , , , et al.
Diagnostic architectural and dynamic features at breast MR imaging: Multicenter study. Radiology 2006; 238: 42–53., , , , , , et al.
Magnetic resonance imaging of the breast prior to biopsy. J Am Med Assoc 2004; 292: 2735–42., , , , , , et al.
Adding in vivo quantitative 1H MR spectroscopy to improve diagnostic accuracy of breast MR imaging: Preliminary results of observer performance study at 4.0 T. Radiology 2005; 236: 465–75., , , , , , et al.
Combined dynamic contrast enhanced breast MR and proton spectroscopic imaging: A feasibility study. J Magn Reson Imaging 2005; 21: 23–8., , , , , .
Benign and malignant breast lesions: Diagnosis with multiparametric MR imaging. Radiology 2003; 229: 225–32., , , , , , et al.
Multiparametric and multinuclear magnetic resonance imaging of human breast cancer: Current applications. Technol Cancer Res Treat 2004; 3: 543–50., , , , , , et al.
Quantitative proton spectroscopy of canine brain: In vivo and in vitro correlations. Magn Reson Med 1994; 32: 157–63., , , , , , et al.
Clinical evaluation of choline measurement by proton MR spectroscopy in patients with malignant tumors. Radiat Med 2004; 22: 148–54., , , , , , et al.
Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. Cancer Res 1999; 59: 80–4., .
Evaluating human breast ductal carcinomas with high-resolution magic-angle spinning proton magnetic resonance spectroscopy. J Magn Reson 1998; 135: 194–202., , , .
Diagnosis and prognosis of breast cancer by magnetic resonance spectroscopy of fine-needle aspirates analysed using a statistical classification strategy. Br J Surg 2001; 88: 1234–40., , , , , , et al.
Imaging in breast cancer: Magnetic resonance spectroscopy. Breast Cancer Res 2005; 7: 149–52., , , .
Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions. J Natl Cancer Inst 2002; 94: 1197–203., , .
Human breast lesions: Characterization with proton MR spectroscopy. Radiology 1998; 209: 269–75., , , .
Characterization of neoplastic and normal human breast tissues with in vivo (1)H MR spectroscopy. J Magn Reson Imaging 1999; 10: 159–64., , , , , , et al.
Potential of magnetic resonance spectroscopy to detect metastasis in axillary lymph nodes in breast cancer. Magn Reson Imaging 2005; 23: 1005–10., , , , , .
Breast cancer: In vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases. Radiology 2002; 225: 190–7., , .
Neoadjuvant chemotherapy of locally advanced breast cancer: Predicting response with in vivo (1)H MR spectroscopy – a pilot study at 4 T. Radiology 2004; 233: 424–31., , , , , , et al.
Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer. Br J Cancer 2001; 84: 1016–22., , , , , , et al.
Strategies for shimming the breast. Magn Reson Med 2005; 54: 1139–45., , , .
Dynamic shim updating: A new approach towards optimized whole brain shimming. Magn Reson Med 1996; 36: 159–65., , .
Automated shimming for deuterated solvents using field profiling. J Magn Reson 1997; 125: 159–62., , , .
Automatic, localized in vivo adjustment of all first- and second-order shim coils. Magn Reson Med 1993; 29: 804–11..
Measurement and correction of respiration-induced B0 variations in breast 1H MRS at 4 Tesla. Magn Reson Med 2004; 52: 1239–45., , , , .
Eliminating spurious lipid sidebands in 1H MRS of breast lesions. Magn Reson Med 2002; 48: 215–22., , , , , , et al.
Proton magnetic resonance spectroscopic imaging of human breast cancer: A preliminary study. J Magn Reson Imaging 2004; 19: 68–75., , , , .
Fat suppression at 7 T using a surface coil: Application of an adiabatic half-passage chemical shift selective radiofrequency pulse. J Magn Reson Imaging 1995; 5: 768–72., , .
WET, a T1- and B1-insensitive water-suppression method for in vivo localized 1 H NMR spectroscopy. J Magn Reson B 1994; 104: 1–10., , .
Simultaneous water and lipid suppression for in vivo brain spectroscopy in humans. Magn Reson Med 2005; 54: 691–6., , , .
Improved water and lipid suppression for 3D PRESS CSI using RF band selective inversion with gradient dephasing (BASING). Magn Reson Med 1997; 38: 311–21., , , , .
Simultaneous in vivo spectral editing and water suppression. NMR Biomed 1998; 11: 266–72., , , , .
An improved 1 H magnetic resonance spectroscopic imaging technique for the human breast: Preliminary results. Magn Reson Imaging 2005; 23: 571–6., , , , .
Elimination of artifacts in short echo time H MR spectroscopy of the frontal lobe. Magn Reson Med 1996; 36: 462–8., .
Sensitivity and localization enhancement in multinuclear in vivo NMR spectroscopy by outer volume presaturation. Magn Reson Med 1993; 30: 661–71., .
ENC. Asilomar, CA, 2004., , , . A protocol for quantitative 3D MR spectroscopic imaging of the human breast.
Reduced phase encoding in spectroscopic imaging. Magn Reson Med 1994; 31: 645–51., , , .
Scan time reduction in proton magnetic resonance spectroscopic imaging of the human brain. Magn Reson Med 2002; 47: 384–7., , , .
Sensitivity-encoded spectroscopic imaging. Magn Reson Med 2001; 46: 713–22., , , , .
High speed 1 H spectroscopic imaging in human brain by echo planar spatial-spectral encoding. Magn Reson Med 1995; 33: 34–40., , , , .
External standard method for the in vivo quantification of choline-containing compounds in breast tumors by proton MR spectroscopy at 1.5 Tesla. Magn Reson Med 2001; 46: 189–92., , , .
In vivo quantification of choline compounds in the breast with 1 H MR spectroscopy. Magn Reson Med 2003; 50: 1134–43., , , , , , et al.
Quantitative proton MR spectroscopic imaging of the human brain. Magn Reson Med 1996; 35: 356–63., , , .
The signal-to-noise ratio of the nuclear magnetic resonance experiment. J Magn Reson 1976; 24: 71–85., .
In vivo 1H NMR spectroscopy of the human brain at 7 T. Magn Reson Med 2001; 46: 451–6., , , , , .
1H chemical shift imaging reveals loss of brain tumor choline signal after administration of Gd-contrast. Magn Reson Med 1997; 37: 222–5., , , , .
Effects of contrast material on single-volume proton MR spectroscopy. Am J Neuroradiol 2000; 21: 1084–9., , .
Evaluation of 1H-magnetic resonance spectroscopy of breast cancer pre- and postgadolinium administration. Invest Radiol 2005; 40: 405–11., , , , , .
Volume localized in vivo proton MR spectroscopy of breast carcinoma: Variation of water–fat ratio in patients receiving chemotherapy. NMR Biomed 1998; 11: 414–22., , , , , , et al.